Pure Global AI
NCT06276881Completed

Visual Stimulation for Pain Relief

Pain Relief Through Artificial Intelligence (AI) -Guided Visual Stimulation
Dandelion ScienceClinicalTrials.govbehavioral
Verified
Study focus
Disease/Condition
Pain
Drug/Device/Intervention
Visual Stimulation
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Dandelion Science
Location
Hoboken, United States of America
Timeline & enrollment
Phase
N/A
Start date
Jun 03, 2022
End date
May 01, 2023
Enrollment
75 participants
Primary outcome

Visual Analog Scale (VAS) Score,Contact Heat Evoked Potential (CHEP)

Summary

The goal of this study is to investigate a novel neuromodulatory approach utilizing visual
 stimulation to impact pain perception in healthy participants.

ICD-10 classifications
Pain, unspecifiedPain, not elsewhere classifiedPain in limbAcute painOther chronic pain
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06276881
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06276881 through Pure Global AI's free database. This phase not specified trial is sponsored by Dandelion Science and is currently Completed. The study focuses on Pain. Target enrollment is 75 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.